SHANGHAI, Feb 11 (Reuters) - Eli Lilly has won Chinese regulators' approval for its drug to treat chronic inflammatory bowel ...

Inflammatory bowel disease (IBD) is an umbrella term for a group of chronic conditions that cause inflammation and swelling ...

Teva Pharmaceutical Industries Limited TEVA shares are higher during Tuesday’s premarket session as the company is discussing ...

The death of "Dawson's Creek" actor James Van Der Beek highlights a rising trend in colorectal cancer among young adults ...

We often treat intestinal infections as an episode: a few days of symptoms, elimination of the pathogen, and recovery. In this view, the disease has a clear beginning and end. However, patient ...

Jaguar has received the initial $16M payment related to the company's recently executed US out-license agreement for ...

Inflammatory bowel disease, or IBD, is an umbrella term for a group of chronic conditions that cause inflammation and swelling in the digestive tract. It primarily includes two conditions: ulcerative ...

Inflammatory bowel disease (IBD) is typically diagnosed after the onset of symptoms in the context of established, characteristic patterns of intestinal inflammation. However, there is now substantial ...

A genetics‑guided drug, compound 6, targets CARD9 to subtly calm gut inflammation in Crohn’s disease, pointing to safer, longer‑lasting, precision treatments.

When the gut is unbalanced with too many harmful organisms, it can lead to unpleasant symptoms in different parts of the body ...

People with inflammatory bowel disease (IBD) and precancerous colorectal lesions are much more likely to develop colorectal cancer, a new study shows. Led by researchers from NYU Langone Health, the ...

The impact of eating spicy foods regularly can trigger changes to your gut and digestion, which can involve both positive and negative effects.